Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
- Image - 546b07bd 7dba 49c9 8caf 7914600d4d19 01
- Image - 546b07bd 7dba 49c9 8caf 7914600d4d19 02
- Image - 546b07bd 7dba 49c9 8caf 7914600d4d19 03
- Image - 546b07bd 7dba 49c9 8caf 7914600d4d19 04
- Label Divalproex Sodium ER Tablets USP 250 mg 100 counts - 546b07bd 7dba 49c9 8caf 7914600d4d19 06
- Label Divalproex Sodium ER Tablets USP 500 mg 100 counts - 546b07bd 7dba 49c9 8caf 7914600d4d19 07
Product Label Images
The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 68001-646 by Bluepoint Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 546b07bd 7dba 49c9 8caf 7914600d4d19 01
Image - 546b07bd 7dba 49c9 8caf 7914600d4d19 02
This text provides information about the percentage reduction in CPS rate using Divalproex Sodium Delayed-Release Tablets compared to a placebo. It shows the percentage of patients with improvement, no change, or worsening in their condition.*
Image - 546b07bd 7dba 49c9 8caf 7914600d4d19 03
This is an evaluation of the reduction in CPS rate based on different percentages, including 100%, 75%, 50%, and 2%. The text also mentions two types of tablets related to high dose and low dose Divalproex Sodium. Additionally, it refers to the percentage of patients in the evaluation.*
Image - 546b07bd 7dba 49c9 8caf 7914600d4d19 04
This text contains information about two medications: Placebo and Divalproex sodium (extended-release tablets). It also mentions a numerical value of p=0.006 along with a list of numbers.*
Label Divalproex Sodium ER Tablets USP 250 mg 100 counts - 546b07bd 7dba 49c9 8caf 7914600d4d19 06
This text is a product description for Divalproex Sodium Extended-Release Tablets. Each film-coated tablet contains 250mg of Divalproex Sodium, USP equivalent to valproic acid. The product is intended for once-daily dosing and comes in a bottle with 100 tablets. The tablets should be stored at 20°C to 25°C (68°F to 77°F) in a tight, light-resistant container. The pharmacist is advised to dispense a Medication Guide to each patient along with the tablets. Additionally, the text emphasizes keeping the medication out of reach of children and not accepting the product if the seal over the bottle opening is broken or missing.*
Label Divalproex Sodium ER Tablets USP 500 mg 100 counts - 546b07bd 7dba 49c9 8caf 7914600d4d19 07
This is a description for an extended-release tablet containing Divalproex Sodium, equivalent to valproic acid 500mg. The usual dosage instructions are provided in the package insert. It is recommended to store the tablets in a USP tight, light-resistant container at a temperature range of 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). It is emphasized to keep the medication out of reach of children. Additionally, the tablets are for once-daily dosing, and pharmacists should provide the accompanying Medication Guide to each patient. The tablets are manufactured by UNICHEM LABORATORIES LTD in India for BluePoint Laboratories.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
